Health & Biotech

Special Report: Shareholders of Dimerix (ASX:DXB) got an early Christmas present with the company telling them its Phase 3 clinical…

This week has been a good time to be a company helping in the front line fight against COVID-19 but…

The ASX 200 Health Index (XHJ) has dropped by almost 5% at the time of writing, compared to the broader…

Special Report: The renewal contract marks the 14th year of collaboration between PharmAust’s subsidiary Epichem and global non-profit organisation, DNDi.

The launch of Pharmacy Own and supply agreement with CH2 will provide consumers with equivalent products to major brands currently…

The ASX 200 Health Index (XHJ) is trading higher by 0.27% at the time of writing, compared to the broader…

Special Report: Priding itself on providing truly organic cannabidiol (CBD) products Dragonfly Biosciences will list on the ASX as it…

Special Report: PharmAust’s clinical trials of monepantel in canines, COVID-19 and motor neurone disease are all expected to start in…

Special Report: The partnership agreement brings together Singapore’s best national research institutes to co-develop the next generation of dental implant…

Special Report: The TGA nod is the first ever in Australia. A breakthrough which gives MGC Pharma partner EXTRAX credibility,…